SEARCH HEALTH CONDITIONS BY ALPHABETS
Nausea/Vomiting, Radiation Induced
Medications for Nausea/Vomiting, Radiation-induced
About Nausea/Vomiting, radiation-induced: Nausea and vomiting caused by Radiation therapy, where highpowered x rays, contaminants, or sterile seeds have been traditionally utilised to kill cancer cells.
Drugs Used to Treat Nausea/Vomiting, Radiation-induced
The following set of medications have been found in the treating this illness, or somehow associated with.
| Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| ondansetron | Rx | B | N | 3 reviews | 6.5 | ||
Generic title: ondansetron systemic Brand titles: Zofran, Zofran ODT, Zuplenz Drug category: 5HT3 receptor antagonists For consumers: dosage, interactions, For professionals: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Zofran | Rx | B | N | 3 reviews | 6.5 | ||
Generic title: ondansetron systemic Drug category: 5HT3 receptor antagonists For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Zofran ODT | Rx | B | N | Insert review | 0.0 | ||
Generic title: ondansetron systemic Drug category: 5HT3 receptor antagonists For consumers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
| granisetron | Rx | B | N | Insert review | 0.0 | ||
Generic title: granisetron systemic Drug category: 5HT3 receptor antagonists For consumers: dosage, interactions, For professionals: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Zuplenz | Rx | B | N | Insert review | 0.0 | ||
Generic title: ondansetron systemic Drug category: 5HT3 receptor antagonists For consumers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
Legend
| Rx | Prescription Only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Off Label | This drug may not be approved by the FDA for treating this illness. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus within the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have demonstrated a negative effect in the fetus and there are no sufficient and well-controlled studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may justify used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with used in pregnant women clearly outweigh potential rewards. |
| N | FDA has not classified the drug. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | Is not at the mercy of the Controlled Substances Act. |
| 1 | Has a higher possibility of abuse. Has no currently accepted medical use in treatment in the United States. There`s just a lack of accepted safety for use under medical supervision. |
| Two | Has a higher possibility of abuse. Features a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may result in acute physical or emotional dependence. |
| 3 | includes a potential for abuse less than individuals in schedules 1 and 2 two. Features a currently accepted medical use in treatment in the United States. Abuse may lead to physical dependence or high psychological dependence. |
| 4 | Has a very low potential for abuse in accordance with individuals in schedule 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| 5 | Has a very low potential for abuse in accordance with individuals in schedule 4. Features a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in schedule 4. |
| Infection | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Runciman
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always ask your healthcare provider to be sure the information displayed on these pages applies to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
